VaramirStart free · no cardSign in
CRSP as of Oct 31 · 00:14 ET
CRSPNasdaqBiological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG · Brief

Next report

9 days

Nov 9 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±6.3%
avg realized
±4.8%
Nov 5 '24±8.8%▼−0.45%×0.05
Feb 11 '25±3.8%▲+9.29%×2.44
May 6 '25±6.4%▲+3.29%×0.52
Aug 4 '25±6.0%▼−6.71%×1.11
Q3 FY25±8.4%▼−0.98%×0.12
Feb 12 '26±3.6%▲+8.46%×2.37
Q1 FY26±5.9%▼−2.24%×0.38
Q2 FY26±7.8%▲+7.06%×0.90
quarterimplied−10%0+10%realized×
Q2 FY26±7.8%▲+7.06%×0.90
Q1 FY26±5.9%▼−2.24%×0.38
Feb '26±3.6%▲+8.46%×2.37
Q3 FY25±8.4%▼−0.98%×0.12
Aug '25±6.0%▼−6.71%×1.11
May '25±6.4%▲+3.29%×0.52
2 older reports
Feb '25±3.8%▲+9.29%×2.44
Nov '24±8.8%▼−0.45%×0.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

5disclosed supplier and customer ties in SEC filingsSEC filings
5tracked funds holding CRSPN-PORT · Aug 31 '26

Bear2 of 3

5 of 8recent reports where the move came in under the options implied rangeEarnings history
9 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CRSP report session

Customers 1

VRTXVertex×0.18
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±8.7% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.